- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1868-7083
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The role of epigenetic modifications for the pathogenesis of Crohn's disease ; volume:13 ; number:1 ; day:12 ; month:5 ; year:2021 ; pages:1-14 ; date:12.2021
Clinical epigenetics ; 13, Heft 1 (12.5.2021), 1-14, 12.2021
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13148-021-01089-3
- URN
-
urn:nbn:de:101:1-2021091221343851492942
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hornschuh, M.
- Wirthgen, E.
- Wolfien, Markus
- Singh, K. P.
- Wolkenhauer, Olaf
- Däbritz, Jan
- SpringerLink (Online service)
Other Objects (12)
Epigenetic modifications in lymphoma: Relevance for pathogenesis and treatment
Gut microbiota induced epigenetic modifications in the non‐alcoholic fatty liver disease pathogenesis
Mapping the epigenetic modifications of DNA and RNA
Epigenetic dynamics of cytidine modifications
Epigenetic dynamics of cytidine modifications
MicroRNAs overexpressed in Crohn’s disease and their interactions with mechanisms of epigenetic regulation explain novel aspects of Crohn’s disease pathogenesis
The role of epigenetic modifications in Colorectal Cancer Metastasis
Defining the phenotype, pathogenesis and treatment of Crohn’s disease associated spondyloarthritis
Epigenetic Markers and Microbiota/Metabolite-Induced Epigenetic Modifications in the Pathogenesis of Obesity, Metabolic Syndrome, Type 2 Diabetes, and Non-alcoholic Fatty Liver Disease
Infection-induced epigenetic changes and the pathogenesis of diseases
Metabolic reprogramming and epigenetic modifications on the path to cancer
Epigenetic Mechanisms in the Pathogenesis and Therapy of Anxiety Disorders
Epigenetic modifications in lymphoma: Relevance for pathogenesis and treatment
Gut microbiota induced epigenetic modifications in the non‐alcoholic fatty liver disease pathogenesis
Mapping the epigenetic modifications of DNA and RNA
Epigenetic dynamics of cytidine modifications
Epigenetic dynamics of cytidine modifications
MicroRNAs overexpressed in Crohn’s disease and their interactions with mechanisms of epigenetic regulation explain novel aspects of Crohn’s disease pathogenesis
The role of epigenetic modifications in Colorectal Cancer Metastasis
Defining the phenotype, pathogenesis and treatment of Crohn’s disease associated spondyloarthritis
Epigenetic Markers and Microbiota/Metabolite-Induced Epigenetic Modifications in the Pathogenesis of Obesity, Metabolic Syndrome, Type 2 Diabetes, and Non-alcoholic Fatty Liver Disease
Infection-induced epigenetic changes and the pathogenesis of diseases
Metabolic reprogramming and epigenetic modifications on the path to cancer
Epigenetic Mechanisms in the Pathogenesis and Therapy of Anxiety Disorders
Epigenetic modifications in lymphoma: Relevance for pathogenesis and treatment
Gut microbiota induced epigenetic modifications in the non‐alcoholic fatty liver disease pathogenesis
Mapping the epigenetic modifications of DNA and RNA
Epigenetic dynamics of cytidine modifications
Epigenetic dynamics of cytidine modifications
MicroRNAs overexpressed in Crohn’s disease and their interactions with mechanisms of epigenetic regulation explain novel aspects of Crohn’s disease pathogenesis
The role of epigenetic modifications in Colorectal Cancer Metastasis
Defining the phenotype, pathogenesis and treatment of Crohn’s disease associated spondyloarthritis
Epigenetic Markers and Microbiota/Metabolite-Induced Epigenetic Modifications in the Pathogenesis of Obesity, Metabolic Syndrome, Type 2 Diabetes, and Non-alcoholic Fatty Liver Disease
Infection-induced epigenetic changes and the pathogenesis of diseases
Metabolic reprogramming and epigenetic modifications on the path to cancer